Partner Victoria A. Lupu has been named a Law360 Rising Star for her incredible work shepherding transformative tech and life sciences mergers and acquisitions worth billions of dollars. In an interview, the outlet highlighted Victoria’s work co-leading fast-moving marquis deals like Databricks’s $1.3 billion acquisition of MosaicML and Alpine Immune Sciences, Inc.' $4.9 billion sale to Vertex Pharmaceuticals. Learn more about the honor here: https://lnkd.in/etYhJKTa #ArtificialIntelligence #MergersAcquisitionsDivestitures #LifeSciences
Fenwick & West’s Post
More Relevant Posts
-
Join me at Dynamic Global Events (DGE)'s 5th Clinical Trial Agreements on August 22nd at 11:45! We'll delve into the pivotal role CTAs play in mergers and acquisitions, especially in pharma and biotech. Learn about key M&A due diligence, the transformative potential of AI in CTAs, and the importance of standard templates for streamlining clinical trials. Click below to register now. #clinicaltrials #clinicaltrialagreements #mergersandacquisitions #DGEvents
To view or add a comment, sign in
-
Seale & Associates, Inc. is pleased to announce the release of the May 2024 edition of our Mergers and Acquisitions (M&A) report for the U.S. This report is an all-inclusive guide that provides details on the transactions carried out by American companies in May. May saw a significant shift in the mergers and acquisitions market in the U.S. A total of 1,144 transactions were announced within the country, a 2.0% increase compared to the same period last year. However, 145 transactions were carried out abroad, indicating an 11.6% decrease from the previous year. The report features notable companies such as Biogen, HI-Bio, AGS Health, and Mariana Oncology, showing the market's continued potential. If you want to receive this exclusive monthly report or any of our industry reports, kindly subscribe at https://lnkd.in/gExMnuBz. Stay ahead of the competition with our detailed analysis and insights. #MergersAndAcquisitions #BusinessReports #MarketTrends #USMarket #FinanceInsights #IndustryAnalysis #SealeAndAssociates #FinancialReports #CorporateTransactions #USCompanies
To view or add a comment, sign in
-
Seale & Associates, Inc. is pleased to announce the release of the May 2024 edition of our Mergers and Acquisitions (M&A) report for the U.S. This report is an all-inclusive guide that provides details on the transactions carried out by American companies in May. May saw a significant shift in the mergers and acquisitions market in the U.S. A total of 1,144 transactions were announced within the country, a 2.0% increase compared to the same period last year. However, 145 transactions were carried out abroad, indicating an 11.6% decrease from the previous year. The report features notable companies such as Biogen, HI-Bio, AGS Health, and Mariana Oncology, showing the market's continued potential. If you want to receive this exclusive monthly report or any of our industry reports, kindly subscribe at https://lnkd.in/gExMnuBz. Stay ahead of the competition with our detailed analysis and insights. #MergersAndAcquisitions #BusinessReports #MarketTrends #USMarket #FinanceInsights #IndustryAnalysis #SealeAndAssociates #FinancialReports #CorporateTransactions #USCompanies
To view or add a comment, sign in
-
Mark your calendar! I’ll be speaking at DGE’s 5th Clinical Trial Agreements on August 22nd at 11:45. Learn about the critical role of CTAs in M&As, AI advancements, M&A due diligence, and the power of standard templates. Click below to register now. #clinicaltrialcompliance #MandA #klf
Join me at Dynamic Global Events (DGE)'s 5th Clinical Trial Agreements on August 22nd at 11:45! We'll delve into the pivotal role CTAs play in mergers and acquisitions, especially in pharma and biotech. Learn about key M&A due diligence, the transformative potential of AI in CTAs, and the importance of standard templates for streamlining clinical trials. Register now. Link in comments. #clinicaltrials #clinicaltrialagreements #mergersandacquisitions #DGEvents
To view or add a comment, sign in
-
Join me at Dynamic Global Events (DGE)'s 5th Clinical Trial Agreements on August 22nd at 11:45! We'll delve into the pivotal role CTAs play in mergers and acquisitions, especially in pharma and biotech. Learn about key M&A due diligence, the transformative potential of AI in CTAs, and the importance of standard templates for streamlining clinical trials. Register now. Link in comments. #clinicaltrials #clinicaltrialagreements #mergersandacquisitions #DGEvents
To view or add a comment, sign in
-
Linkedin Top Voice| Life Science Lawyer | Board Member | Entrepreneur | Educator, Author, and Speaker
Mark your calendar! I’ll be speaking at DGE’s 5th Clinical Trial Agreements on August 22nd at 11:45. Learn about the critical role of CTAs in M&As, AI advancements, M&A due diligence, and the power of standard templates. Click below to register now. #clinicaltrialcompliance #MandA #klf
Join me at Dynamic Global Events (DGE)'s 5th Clinical Trial Agreements on August 22nd at 11:45! We'll delve into the pivotal role CTAs play in mergers and acquisitions, especially in pharma and biotech. Learn about key M&A due diligence, the transformative potential of AI in CTAs, and the importance of standard templates for streamlining clinical trials. Register now. Link in comments. #clinicaltrials #clinicaltrialagreements #mergersandacquisitions #DGEvents
To view or add a comment, sign in
-
Seale & Associates, Inc. is pleased to announce the release of the May 2024 edition of our Mergers and Acquisitions (M&A) report for the U.S. This report is an all-inclusive guide that provides details on the transactions carried out by American companies in May. May saw a significant shift in the mergers and acquisitions market in the U.S. A total of 1,144 transactions were announced within the country, a 2.0% increase compared to the same period last year. However, 145 transactions were carried out abroad, indicating an 11.6% decrease from the previous year. The report features notable companies such as Biogen, HI-Bio, AGS Health, and Mariana Oncology, showing the market's continued potential. If you want to receive this exclusive monthly report or any of our industry reports, kindly subscribe at https://lnkd.in/gExMnuBz. Stay ahead of the competition with our detailed analysis and insights. #MergersAndAcquisitions #BusinessReports #MarketTrends #USMarket #IndustryAnalysis #SealeAndAssociates #FinancialReports #CorporateTransactions #USCompanies
To view or add a comment, sign in
-
The two headlines in my inbox this morning give a clue of what pharma will look like over the next year: (1) significant patent cliff exposure and (2) losing the reimbursement reform with the US government. Taken together we’ll see all eyes on big pharma mergers. And what do companies do when they’re getting ready for big M&A activity? They compress further — like fasting before heading off to digest a large meal. Conditions to do beyond “the core” (aka the minimum with business-as-usual) and drive progress in the field may remain unfavorable.
To view or add a comment, sign in
-
Exciting news for the pharma industry! A recent report predicts an uptick in mergers and acquisitions in 2024, continuing the trend from this year. Read more about the forecasted growth. #PharmaNews #MergersAndAcquisitions
To view or add a comment, sign in
-
In a shifting healthcare landscape, smaller, focused acquisitions are proving more fruitful for big pharma. Are you leveraging strategic acquisitions to drive growth and innovation in your industry? Bennett Thrasher's Transaction Advisory Services team brings real-world, hands-on expertise to the table. We evaluate potential investments through the lens of a dealmaker to add value to your acquisition process. #Biopharma #HealthCare #MergersAndAcquisitions #TransactionAdvice https://lnkd.in/ejrw8bRB
For biopharma M&A, the best returns come from small deals
To view or add a comment, sign in
18,554 followers